Syrup or extract at the first signs of symptoms.
⏱ 3 min read
Black elderberry, or Sambucus nigra, is a common shrub in Europe, western Asia, and northern Africa whose flowers and ripe fruits have been used for centuries in traditional European medicine for respiratory infections, fever, and skin problems; ripe elderberries (which must be eaten cooked, since raw berries and green parts contain potentially toxic cyanogenic glycosides) are the basis of several modern medicinal preparations with clinical support for reducing the duration and severity of viral respiratory infections, particularly influenza and common colds, where several randomized trials have documented relevant clinical efficacy.
The identified active components are anthocyanins (especially cyanidin-3-glucoside and cyanidin-3-sambubioside, responsible for the intense purple color of the berries), flavonoids (quercetin, rutin), phenolic acids, and lectins with antiviral activity documented in vitro against several respiratory viruses (especially influenza A and B viruses and respiratory syncytial virus); the proposed mechanisms include inhibition of viral binding to host cells, inhibition of viral neuraminidase (a mechanism analogous to that of oseltamivir/Tamiflu), and modulation of the host's antiviral immune response.
The indication with the strongest clinical support is reducing the duration and severity of influenza symptoms: several randomized trials have documented reductions of 3-4 days in symptom duration with standardized elderberry extracts (especially Sambucol and similar) given for 5 days from symptom onset, with effect sizes comparable to those of pharmaceutical oseltamivir but without the toxicity and availability problems of the antiviral.
A randomized Israeli trial published in 1995 in patients with virologically documented influenza showed significant reductions in symptom duration with elderberry extract (Sambucol) given for 3 days; later studies in other populations and with different formulations have confirmed the results with consistent effect sizes.
In the common cold, several studies have documented modest reductions in symptom duration and severity with supplementation started within the first 48 hours of symptom onset, an indication consistent with the influenza data and with moderate clinical support.
The doses studied are typically 15 milliliters of standardized elderberry syrup (Sambucol and similar) 4 times a day for 5 days from symptom onset, or the equivalent in capsules or lozenges; prophylactic doses for prevention (1-2 tablespoons/day during higher-risk seasons) have weaker data but may have a place; early initiation (first 48 hours) is clinically more important than the duration of treatment, according to the available trials.
The most important safety consideration is the toxicity of raw berries and green parts of the plant (leaves, stems, unripe seeds): they contain cyanogenic glycosides (especially sambunigrin) that can cause poisoning with nausea, vomiting, diarrhea, and, in severe cases, systemic manifestations; commercial products use exclusively ripe berries that have been cooked or properly processed to eliminate the cyanogenic glycosides, and are safe at the usual doses; never consume raw berries or green parts of the plant as a home remedy; people with active autoimmune diseases should be cautious because of the theoretical immunostimulatory activity (although clinical data show no signals of significant exacerbation); those taking immunosuppressants should consult first; in pregnancy and breastfeeding, specific data are limited and use at therapeutic doses is discouraged as a precaution, although small dietary amounts (well-processed elderberry jam or wine) are traditional and apparently safe; in children, specific pediatric formulations are a reasonable option for viral respiratory infections under supervision; people with diabetes should be cautious with commercial syrups that contain significant added sugar; standardized commercial products (Sambucol and similar) are significantly better studied than generic non-standardized products or homemade preparations, and are the option of choice for therapeutic use.
Information, not medical advice. Scientific evidence reflects the quality of the studies.